Financials

  • Market Capitalization 65.72 M
  • Employee 51
  • Founded 2001
  • CEO Marc Voigt
  • Website www.immutep.com
  • Headquarter Australia
  • FIGI BBG002WD6SY6
  • Industry Biotechnology

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4171
PMVP
PMV Pharmaceuticals, Inc. - Common Stock
1.40 USD+9.38%+15.70%+26.13%+5.26%74.66 M USD
4177
MNOV
MediciNova, Inc. - Common Stock
1.37 USD+0.74%-4.86%+7.87%+13.22%67.43 M USD
4185
HYFT
MindWalk Holdings Corp. - Common Stock
1.43 USD+1.42%-10.06%-13.33%-29.21%66.00 M USD
4194
DOMH
Dominari Holdings Inc. - Common Stock
2.78 USD-0.36%-1.42%-16.01%-48.04%62.87 M USD

Frequently asked questions about Immutep Limited - American Depositary Shares

What is the Immutep Limited - American Depositary Shares stock price today?

The current price of Immutep Limited - American Depositary Shares (IMMP) is 0.45. Over the past 24 hours, the stock has changed by +7.14%. Follow the IMMP chart for real-time price dynamics.

What is the stock ticker of Immutep Limited - American Depositary Shares?

Immutep Limited - American Depositary Shares trades under the ticker IMMP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Immutep Limited - American Depositary Shares stock going up?

IMMP has changed by +4.65% over the last week, +25.00% over the last month, and -73.37% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Immutep Limited - American Depositary Shares have?

As of the latest available data, Immutep Limited - American Depositary Shares has 51 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Immutep Limited - American Depositary Shares stock?

You can buy Immutep Limited - American Depositary Shares (IMMP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Immutep Limited - American Depositary Shares stock?

Investing in Immutep Limited - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMMP chart and related analysis on metatrader.com as part of your research.

Immutep Limited - American Depositary Shares

Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech. Prima currently has three main products in its pipeline, all acquired with Immutep: Eftilagimod alpha, which is recombinant soluble LAG-3, used as an activator of antigen presenting cells. This product has completed a Phase IIa clinical study, where it doubled the expected response rate in HER2-negative metastatic breast cancer. IMP731, a depleting monoclonal antibody for autoimmune diseases, targeting LAG-3+ activated T cells. This antibody has been licensed to GlaxoSmithKline. IMP701, an antagonist monoclonal antibody to LAG3 for use in cancer. This product has been licensed to Novartis.

News